http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006076434-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27f3e661c1f315a826df3c20e5472dda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02177870fe9ddbad9cb0733f9853321d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-906
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-534
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-752
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N65-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899
filingDate 2006-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee96c1413faf6bfcec493f74a4a2a495
publicationDate 2007-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006076434-A3
titleOfInvention Improved cox-2 inhibitory compositions and therapeutic regimen
abstract This invention provides improved COX-2 inhibitory compositions comprising a combination of a selective inhibitor of COX-2 and a prostacyclin promoter, especially an antioxidant of the type known as food extracts. The invention also provides a regimen treating a disease that is responsive to inhibition of cyclooxygenase-2, comprising administering to a patient suffering from such a disease the combination of the invention comprising a selective inhibitor of COX-2 and a prostacyclin promoter in amounts and at intervals effective to therapeutically inhibit COX-2 while maintaining a therapeutically significant level of prostacyclin production.
priorityDate 2005-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6184248-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003013739-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004044028-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6264995-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282411

Total number of triples: 35.